5/6, 6:38 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Pfizer Inc

Pfizer CEO opposes US call for vaccine patent waiver

Pfizer's Chief Executive Officer Albert Bourla said on Thursday that he and his company are against waiving patent protections for coronavirus vaccines as proposed by the United States earlier.

In an interview with AFP, Bourla said the move wouldn't help increase production of vaccine doses and suggested ramping up production at existing facilities instead.

Earlier this week, Pfizer said it expects to make $26 billion this year from sales of its COVID-19 shot, which will most likely be required on an annual basis.

Breaking the News / JC